×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Sarepta Therapeutics Inc. (SRPT) NASDAQ

$122.84 (2.16) (-1.73%)

Market Cap: $11.61B

As of 06/14/24 04:00 PM EDT. Market closed.

(SRPT)

Sarepta Therapeutics Inc. (SRPT)
NASDAQ

$122.84
(2.16) (-1.73%)

Market Cap: $11.61B

As of 06/14/24 04:00 PM EDT. Market closed.

Add to Portfolio

sarepta therapeutics is a biopharmaceutical company focused on the discovery and development of unique rna-targeted therapeutics for the treatment of rare, infectious and other diseases. the company is primarily focused on rapidly advancing the development of its potentially disease-modifying dmd drug candidates, including its lead dmd product candidate, eteplirsen, designed to skip exon 51. ... read more

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Douglas Ingram
Full Time Employees
1,326
URL
Address
215 1st St Ste 415, Massachusetts, Cambridge, 02142-1213.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Douglas Ingram
Full Time Employees
1,326
CEO Compensation (Base)
$650,000
Address
215 1st St Ste 415, Massachusetts, Cambridge, 02142-1213.
PRICE CHART FOR SAREPTA THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$125
Days Range
$120.34 - $125.52
52 week range
$55.25 - $146.68
Volume
1,000,460
Avg. Volume (30 days)
2,320,031
Market Cap
$11.61B
Dividend Yield
-
P/E
687.18
Shares Outstanding
94,523,766
Open
-
Previous Close
$125
Days Range
$120.34 - $125.52
52 week range
$55.25 - $146.68
Volume
1,000,460
Avg. Volume (30 days)
2,320,031
Market Cap
$11.61B
Dividend Yield
-
P/E
687.18
Shares Outstanding
94,523,766
FINANCIAL STATEMENTS FOR SAREPTA THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR SAREPTA THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Murray DallanChief Customer OfficerMay 02, 2024 Sale$140.003,635508,90018,125May 06, 2024, 08:09 PM
Wigzell Hans Lennart RudolfDirectorMar 08, 2024 Option Exercise$13.9015,000208,50037,840Mar 11, 2024, 08:02 PM
Wigzell Hans Lennart RudolfDirectorMar 08, 2024 Sale$123.2515,0001,848,79534,685Mar 11, 2024, 08:02 PM
Arif BilalChief Tech Ops OfficerMar 08, 2024 Option Exercise$123.1447258,12225,222Mar 11, 2024, 08:00 PM
Arif BilalChief Tech Ops OfficerMar 07, 2024 Option Exercise$120.4950660,96825,694Mar 11, 2024, 08:00 PM
Rodino-Klapac LouiseHead of R&D, CSOMar 07, 2024 Option Exercise$120.4951261,69168,982Mar 11, 2024, 08:00 PM
Rodino-Klapac LouiseHead of R&D, CSOMar 08, 2024 Option Exercise$123.14909111,93468,073Mar 11, 2024, 08:00 PM
Boor Kathryn JeanDirectorMar 11, 2024 Sale$122.9376193,5507,516Mar 11, 2024, 08:00 PM
Brown Ryan EdwardEVP, General CounselMar 08, 2024 Option Exercise$123.14899110,70328,688Mar 11, 2024, 08:00 PM
Brown Ryan EdwardEVP, General CounselMar 07, 2024 Option Exercise$120.4950660,96829,587Mar 11, 2024, 08:00 PM
Estepan Ian MichaelChief Financial OfficerMar 08, 2024 Option Exercise$123.141,035127,45036,164Mar 11, 2024, 08:00 PM
Estepan Ian MichaelChief Financial OfficerMar 07, 2024 Option Exercise$120.4952663,37837,199Mar 11, 2024, 08:00 PM
Estepan Ian MichaelChief Financial OfficerMar 04, 2024 Option Exercise$125.321,389174,06937,725Mar 06, 2024, 08:00 PM
Mayo StephenDirectorMar 05, 2024 Sale$122.963,135385,4806,621Mar 06, 2024, 08:00 PM
Brown Ryan EdwardEVP, General CounselMar 04, 2024 Option Exercise$125.321,734217,30530,093Mar 06, 2024, 08:00 PM
Arif BilalChief Tech Ops OfficerMar 04, 2024 Option Exercise$125.3252265,41726,437Mar 06, 2024, 08:00 PM
Rodino-Klapac LouiseHead of R&D, CSOMar 04, 2024 Option Exercise$125.321,728216,55369,494Mar 06, 2024, 08:00 PM
Arif BilalChief Tech Ops OfficerMar 01, 2024 Option Exercise$126.1936546,05926,722Mar 05, 2024, 08:00 PM
Arif BilalChief Tech Ops OfficerMar 01, 2024 Sale$128.842,000257,67627,293Mar 05, 2024, 08:00 PM
Estepan Ian MichaelChief Financial OfficerMar 01, 2024 Option Exercise$126.1936546,05934,314Mar 05, 2024, 08:00 PM
Estepan Ian MichaelChief Financial OfficerMar 01, 2024 Sale$128.301,200153,96039,114Mar 05, 2024, 08:00 PM
Brown Ryan EdwardEVP, General CounselMar 01, 2024 Option Exercise$126.1926933,94527,827Mar 05, 2024, 08:00 PM
Brown Ryan EdwardEVP, General CounselMar 01, 2024 Sale$125.342,000250,68031,827Mar 05, 2024, 08:00 PM
Rodino-Klapac LouiseHead of R&D, CSOMar 01, 2024 Option Exercise$126.1977898,17665,222Mar 05, 2024, 08:00 PM
Arif BilalChief Tech Ops OfficerDec 01, 2023 Option Exercise$80.343,682295,81222,886Dec 05, 2023, 08:00 PM
Rodino-Klapac LouiseHead of R&D, CSONov 17, 2023 Option Exercise$82.984,508374,07465,751Nov 20, 2023, 08:00 PM
Barry RichardDirectorNov 03, 2023 Buy$78.8110,000788,10010,000Nov 06, 2023, 08:00 AM
Barry RichardDirectorNov 03, 2023 Buy$78.8140,0003,152,400140,000Nov 06, 2023, 08:00 AM
INGRAM DOUGLAS SPresident & CEONov 03, 2023 Buy$79.3625,2252,001,800390,307Nov 06, 2023, 08:00 AM
BEHRENS M KATHLEENDirectorNov 03, 2023 Option Exercise$29.0315,000435,450174,993Nov 06, 2023, 08:00 AM
Chambers Michael AndrewDirectorAug 14, 2023 Buy$109.479,9791,092,429246,996Aug 15, 2023, 08:00 AM
Chambers Michael AndrewDirectorAug 11, 2023 Buy$108.0523,6862,559,272237,017Aug 14, 2023, 08:00 AM
Chambers Michael AndrewDirectorAug 10, 2023 Buy$106.1534,8673,701,067213,331Aug 11, 2023, 07:40 AM
Wigzell Hans Lennart RudolfDirectorAug 04, 2023 Option Exercise$29.0315,000435,45035,994Aug 08, 2023, 08:00 PM
Wigzell Hans Lennart RudolfDirectorAug 04, 2023 Sale$106.7215,0001,600,80020,994Aug 08, 2023, 08:00 PM
Brown Ryan EdwardEVP, General CounselJun 01, 2023 Option Exercise$123.608911,00028,096Jun 05, 2023, 08:00 PM
Arif BilalChief Tech Ops OfficerMar 30, 2023 Option Exercise$136.6630741,95526,367Apr 04, 2023, 08:00 PM
Rodino-Klapac LouiseHead of R&D, CSOMar 08, 2023 Option Exercise$153.19912139,70970,170Mar 10, 2023, 08:00 PM
Estepan Ian MichaelChief Financial OfficerMar 08, 2023 Option Exercise$153.19744113,97334,679Mar 10, 2023, 08:00 PM
Brown Ryan EdwardSVP, General CounselMar 08, 2023 Option Exercise$153.1963597,27628,185Mar 10, 2023, 08:00 PM
Arif BilalChief Tech Ops OfficerMar 08, 2023 Option Exercise$153.1931448,10226,674Mar 10, 2023, 08:00 PM
Arif BilalChief Tech Ops OfficerMar 06, 2023 Option Exercise$157.2134053,45122,642Mar 08, 2023, 08:00 PM
Estepan Ian MichaelChief Financial OfficerMar 06, 2023 Option Exercise$157.211,370215,37830,923Mar 08, 2023, 08:00 PM
Rodino-Klapac LouiseHead of R&D, CSOMar 06, 2023 Option Exercise$157.211,134178,27666,582Mar 08, 2023, 08:00 PM
Brown Ryan EdwardSVP, General CounselMar 06, 2023 Option Exercise$157.211,325208,30324,491Mar 08, 2023, 08:00 PM
Arif BilalChief Tech Ops OfficerMar 01, 2023 Option Exercise$147.5725237,18822,837Mar 03, 2023, 08:01 PM
Brown Ryan EdwardSVP, General CounselMar 01, 2023 Option Exercise$147.5719628,92425,645Mar 03, 2023, 08:01 PM
Estepan Ian MichaelChief Financial OfficerMar 01, 2023 Option Exercise$147.5737855,78132,293Mar 03, 2023, 08:00 PM
Rodino-Klapac LouiseHead of R&D, CSOMar 01, 2023 Option Exercise$147.5752277,03267,716Mar 03, 2023, 08:00 PM
BEHRENS M KATHLEENDirectorDec 19, 2022 Option Exercise$34.9220,000698,400158,470Dec 21, 2022, 09:05 AM
Rodino-Klapac LouiseHead of R&D, CSONov 17, 2022 Option Exercise$108.524,211456,97867,998Nov 21, 2022, 08:02 PM
Mayo StephenDirectorNov 17, 2022 Sale$109.9285894,3116,387Nov 21, 2022, 08:00 PM
Chambers Michael AndrewDirectorSep 14, 2022 Buy$104.4357,1005,963,124108,178Sep 15, 2022, 08:00 AM
Chambers Michael AndrewDirectorAug 19, 2022 Buy$108.2846,1704,999,23051,078Aug 22, 2022, 08:30 AM
Brown Ryan EdwardSVP, General CounselJun 01, 2022 Option Exercise$72.67543,92425,841Jun 03, 2022, 08:00 PM
Estepan Ian MichaelChief Financial OfficerMar 07, 2022 Option Exercise$79.3639831,58524,671Mar 08, 2022, 08:02 PM
Estepan Ian MichaelChief Financial OfficerMar 04, 2022 Option Exercise$79.201,308103,59425,069Mar 08, 2022, 08:02 PM
Brown Ryan EdwardSVP, General CounselMar 07, 2022 Option Exercise$79.3615312,14217,895Mar 08, 2022, 08:02 PM
Brown Ryan EdwardSVP, General CounselMar 04, 2022 Option Exercise$79.201,13689,97118,048Mar 08, 2022, 08:02 PM
Ciambrone WilliamEVPMar 04, 2022 Option Exercise$79.201,16091,87214,099Mar 08, 2022, 08:01 PM
Rodino-Klapac LouiseHead of R&D, CSOMar 04, 2022 Option Exercise$79.201,21696,30764,111Mar 08, 2022, 08:00 PM
Rodino-Klapac LouiseHead of R&D, CSOMar 01, 2022 Option Exercise$75.0557242,92965,327Mar 01, 2022, 08:03 PM
Estepan Ian MichaelChief Financial OfficerMar 01, 2022 Option Exercise$75.0537628,21926,377Mar 01, 2022, 08:02 PM
Brown Ryan EdwardSVP, General CounselMar 01, 2022 Option Exercise$75.0518413,80919,184Mar 01, 2022, 08:01 PM
BEHRENS M KATHLEENDirectorDec 15, 2021 Option Exercise$10.085,00050,400135,517Dec 16, 2021, 08:00 PM
Rodino-Klapac LouiseHead of R&D, CSONov 24, 2021 Buy$79.333,780299,86765,678Nov 29, 2021, 08:00 AM
INGRAM DOUGLAS SPresident & CEONov 17, 2021 Buy$79.9425,0262,000,579365,082Nov 17, 2021, 06:24 PM
Estepan Ian MichaelChief Financial OfficerSep 08, 2021 Option Exercise$78.291,623127,06526,753Sep 09, 2021, 08:00 PM
INGRAM DOUGLAS SPresident & CEOJun 26, 2021 Option Exercise$80.4017,8121,432,085340,056Jun 28, 2021, 08:00 PM
BEHRENS M KATHLEENDirectorMar 10, 2021 Option Exercise$42.305,000211,500135,517Mar 10, 2021, 08:04 PM
BEHRENS M KATHLEENDirectorMar 10, 2021 Sale$85.765,000428,800130,517Mar 10, 2021, 08:04 PM
Wigzell Hans Lennart RudolfDirectorMar 08, 2021 Option Exercise$34.9210,000349,20026,518Mar 10, 2021, 08:03 PM
Wigzell Hans Lennart RudolfDirectorMar 08, 2021 Sale$83.5110,000835,10016,518Mar 10, 2021, 08:03 PM
O'Neill Gilmore NeilEVP, R&D & CMOFeb 28, 2021 Option Exercise$86.9752445,57213,546Mar 10, 2021, 08:02 PM
Brown Ryan EdwardSVP, General CounselMar 04, 2021 Option Exercise$80.7619015,34419,432Mar 10, 2021, 08:01 PM
Brown Ryan EdwardSVP, General CounselFeb 28, 2021 Option Exercise$86.9721618,7864,622Mar 10, 2021, 08:01 PM
Rodino-Klapac LouiseChief Scientific OfficerFeb 28, 2021 Option Exercise$86.9756549,1386,604Mar 10, 2021, 08:01 PM
Estepan Ian MichaelChief Financial OfficerFeb 28, 2021 Option Exercise$86.9731927,74313,723Mar 10, 2021, 08:00 PM
Estepan Ian MichaelChief Financial OfficerMar 05, 2021 Option Exercise$84.6534729,37428,376Mar 10, 2021, 08:00 PM
INGRAM DOUGLAS SPresident & CEODec 31, 2020 Option Exercise$170.4937,1446,332,681357,868Jan 04, 2021, 08:00 PM
Bratica JosephPrincipal Financial OfficerDec 11, 2020 Option Exercise$71.451,11579,6679,255Dec 14, 2020, 08:00 PM
Bratica JosephPrincipal Financial OfficerDec 11, 2020 Sale$165.001,115183,9758,140Dec 14, 2020, 08:00 PM
Bratica JosephPrincipal Financial OfficerDec 08, 2020 Option Exercise$29.601,12533,3009,265Dec 10, 2020, 08:23 PM
Bratica JosephPrincipal Financial OfficerDec 08, 2020 Sale$160.001,125180,0008,140Dec 10, 2020, 08:23 PM
Wigzell Hans Lennart RudolfDirectorAug 10, 2020 Option Exercise$34.9210,000349,20023,792Aug 11, 2020, 08:00 PM
Wigzell Hans Lennart RudolfDirectorAug 10, 2020 Sale$159.0010,0001,590,04414,569Aug 11, 2020, 08:00 PM
Barry RichardDirectorAug 07, 2020 Sale$158.5030,0004,754,9723,132,280Aug 07, 2020, 08:00 PM
Bratica JosephPrincipal Financial OfficerAug 03, 2020 Option Exercise$29.601,12533,3008,957Aug 05, 2020, 08:00 PM
Bratica JosephPrincipal Financial OfficerAug 03, 2020 Sale$155.001,125174,3757,832Aug 05, 2020, 08:00 PM
Mahatme SandeshEVP, CFO & CBOJul 08, 2020 Option Exercise$19.693,80674,94120,260Jul 09, 2020, 08:00 PM
Howton David TEVP, General CounselJun 22, 2020 Option Exercise$25.76105,1222,708,440136,993Jun 22, 2020, 09:17 PM
Howton David TEVP, General CounselJun 22, 2020 Sale$170.88105,12217,962,831130,984Jun 22, 2020, 09:17 PM
Wigzell Hans Lennart RudolfDirectorMay 20, 2020 Option Exercise$10.085,00050,40018,792May 22, 2020, 08:00 PM
Wigzell Hans Lennart RudolfDirectorMay 20, 2020 Sale$150.645,000753,21016,692May 22, 2020, 08:00 PM
Barry RichardDirectorMay 15, 2020 Sale$141.2630,0004,237,9463,163,813May 15, 2020, 09:02 PM
Wigzell Hans Lennart RudolfDirectorMar 04, 2020 Option Exercise$8.465,00042,30018,792Mar 06, 2020, 08:01 PM
Wigzell Hans Lennart RudolfDirectorMar 04, 2020 Sale$116.895,000584,45013,792Mar 06, 2020, 08:01 PM
INGRAM DOUGLAS SPresident & CEODec 31, 2019 Option Exercise$129.0437,1854,798,352395,012Jan 03, 2020, 08:00 PM
Cumbo AlexanderEVP, Chief Commercial OfficerDec 13, 2019 Option Exercise$23.7032,706775,23243,867Dec 17, 2019, 08:02 PM
Cumbo AlexanderEVP, Chief Commercial OfficerDec 13, 2019 Sale$125.5042,0005,271,00011,161Dec 17, 2019, 08:02 PM
Howton David TEVP, General CounselDec 13, 2019 Option Exercise$21.4878,0001,675,439103,171Dec 17, 2019, 08:01 PM
Howton David TEVP, General CounselDec 13, 2019 Sale$125.5078,0009,789,00025,171Dec 17, 2019, 08:01 PM
Mahatme SandeshEVP, CFO & CBODec 13, 2019 Option Exercise$28.88125,0003,610,443155,179Dec 17, 2019, 08:00 PM
Mahatme SandeshEVP, CFO & CBODec 13, 2019 Sale$125.50125,00015,687,50030,179Dec 17, 2019, 08:00 PM
Howton David TEVP, General CounselNov 22, 2019 Option Exercise$107.022,804300,08425,171Nov 26, 2019, 08:01 PM
Howton David TEVP, General CounselNov 22, 2019 Option Exercise$16.1334,272552,66736,993Nov 26, 2019, 08:01 PM
Howton David TEVP, General CounselNov 22, 2019 Sale$105.0025,0002,625,00018,703Nov 26, 2019, 08:01 PM
Barry RichardDirectorSep 13, 2019 Buy$87.493,309289,5043,187,065Sep 16, 2019, 08:00 AM
Barry RichardDirectorSep 12, 2019 Buy$87.491,691147,9503,183,756Sep 16, 2019, 08:00 AM
BONNEY MICHAEL WDirectorSep 09, 2019 Buy$86.742,000173,4807,051Sep 09, 2019, 02:18 PM
BEHRENS M KATHLEENDirectorSep 05, 2019 Option Exercise$7.805,00039,000123,167Sep 06, 2019, 02:13 PM
BEHRENS M KATHLEENDirectorSep 06, 2019 Buy$87.982,500219,950125,667Sep 06, 2019, 02:13 PM
Mahatme SandeshEVP, CFO & CBOAug 21, 2019 Option Exercise$101.5057,4655,832,69872,714Aug 22, 2019, 07:20 PM
Mahatme SandeshEVP, CFO & CBOAug 21, 2019 Option Exercise$23.85100,0002,385,000130,179Aug 22, 2019, 07:20 PM
Barry RichardDirectorAug 20, 2019 Buy$99.325,000496,5923,182,065Aug 20, 2019, 05:43 PM
Mahatme SandeshEVP, CFO & CBOAug 15, 2019 Option Exercise$24.739,754241,23230,179Aug 15, 2019, 04:33 PM
Barry RichardDirectorAug 14, 2019 Buy$122.503,700453,2503,177,065Aug 14, 2019, 04:38 PM
Barry RichardDirectorAug 12, 2019 Buy$122.501,300159,2503,173,365Aug 13, 2019, 04:31 PM
INGRAM DOUGLAS SPresident & CEOAug 12, 2019 Buy$123.0716,2522,000,160432,197Aug 12, 2019, 05:48 PM
O'Neill Gilmore NeilEVP, R&D & CMOMay 24, 2019 Option Exercise$119.314,630552,4057,370May 24, 2019, 08:07 PM
Wigzell Hans Lennart RudolfDirectorMay 23, 2019 Option Exercise$7.8010,00078,00021,717May 24, 2019, 08:03 PM
Wigzell Hans Lennart RudolfDirectorMay 23, 2019 Sale$120.0010,0001,200,00011,717May 24, 2019, 08:03 PM
Mahatme SandeshEVP, CFO & CBOMar 28, 2019 Option Exercise$118.682,953350,46220,425Mar 29, 2019, 08:01 PM
Howton David TEVP, General CounselMar 28, 2019 Option Exercise$118.682,362280,32218,703Mar 29, 2019, 08:00 PM
Cumbo AlexanderEVP, Chief Commercial OfficerMar 28, 2019 Option Exercise$118.682,165256,94211,161Mar 29, 2019, 07:59 PM
Mahatme SandeshEVP, CFO & CBOMar 19, 2019 Option Exercise$126.472,625331,98416,729Mar 20, 2019, 08:00 PM
Mahatme SandeshEVP, CFO & CBOMar 19, 2019 Option Exercise$21.4615,486332,30819,354Mar 20, 2019, 08:00 PM
Mahatme SandeshEVP, CFO & CBOFeb 07, 2019 Option Exercise$23.8565,0001,550,25073,649Feb 08, 2019, 08:02 PM
Mahatme SandeshEVP, CFO & CBOFeb 07, 2019 Sale$145.0065,0009,425,0008,649Feb 08, 2019, 08:02 PM
Cumbo AlexanderSVP, Chief Commercial OfficerFeb 01, 2019 Option Exercise$22.547,500169,03530,266Feb 01, 2019, 08:27 PM
Cumbo AlexanderSVP, Chief Commercial OfficerFeb 01, 2019 Sale$140.0015,0002,100,00015,266Feb 01, 2019, 08:27 PM
Howton David TSVP, General CounselFeb 01, 2019 Option Exercise$21.6521,500465,39149,571Feb 01, 2019, 08:25 PM
Howton David TSVP, General CounselFeb 01, 2019 Sale$140.0030,0004,200,00019,571Feb 01, 2019, 08:25 PM
Mahatme SandeshEVP, CFO & CBOJan 31, 2019 Option Exercise$23.8521,198505,57229,847Feb 01, 2019, 08:24 PM
Mahatme SandeshEVP, CFO & CBOJan 30, 2019 Option Exercise$18.2743,802800,07752,451Feb 01, 2019, 08:24 PM
Mahatme SandeshEVP, CFO & CBOJan 31, 2019 Sale$130.7221,1982,771,0038,649Feb 01, 2019, 08:24 PM
Mahatme SandeshEVP, CFO & CBOJan 30, 2019 Sale$130.0043,8025,694,2608,649Feb 01, 2019, 08:24 PM
Wigzell Hans Lennart RudolfDirectorNov 01, 2018 Option Exercise$8.946,66759,60316,751Nov 02, 2018, 06:01 PM
Wigzell Hans Lennart RudolfDirectorNov 01, 2018 Sale$140.506,667936,71410,084Nov 02, 2018, 06:01 PM
BEHRENS M KATHLEENDirectorOct 31, 2018 Option Exercise$3.9610,00039,600126,534Nov 02, 2018, 06:00 PM
BEHRENS M KATHLEENDirectorOct 31, 2018 Sale$131.7110,0001,317,100116,534Nov 02, 2018, 06:00 PM
INGRAM DOUGLAS SPresident & CEOOct 30, 2018 Buy$120.3916,6952,009,872415,945Oct 30, 2018, 07:05 PM
Mahatme SandeshEVP, CFO & CBOOct 24, 2018 Option Exercise$14.8889,4001,330,389128,185Oct 26, 2018, 06:43 PM
Mahatme SandeshEVP, CFO & CBOOct 24, 2018 Sale$127.74107,52413,735,11620,661Oct 26, 2018, 06:43 PM
INGRAM DOUGLAS SPresident & CEOAug 15, 2018 Buy$125.2616,0002,004,208399,250Aug 16, 2018, 07:30 AM
Cumbo AlexanderSVP, Chief Commercial OfficerAug 08, 2018 Option Exercise$121.026,000726,12022,766Aug 08, 2018, 06:16 PM
Howton David TSVP, General CounselAug 08, 2018 Option Exercise$121.026,800822,93628,071Aug 08, 2018, 06:14 PM
Mahatme SandeshEVP, CFO & CBOAug 08, 2018 Option Exercise$121.028,5011,028,79138,785Aug 08, 2018, 06:14 PM
Howton David TSVP, General CounselJul 16, 2018 Option Exercise$13.8550,000692,69172,719Jul 17, 2018, 06:01 PM
Howton David TSVP, General CounselJul 16, 2018 Sale$136.4650,0006,823,00034,871Jul 17, 2018, 06:01 PM
Cumbo AlexanderSVP, Chief Commercial OfficerJul 09, 2018 Option Exercise$13.7833,782465,41540,690Jul 11, 2018, 06:05 PM
Cumbo AlexanderSVP, Chief Commercial OfficerJul 09, 2018 Sale$137.3233,7824,638,94428,766Jul 11, 2018, 06:05 PM
Barry RichardDirectorJun 27, 2018 Sale$130.3475,0009,775,5003,170,432Jun 29, 2018, 06:01 PM
INGRAM DOUGLAS SPresident & CEOJun 26, 2018 Option Exercise$135.5336,9465,007,291383,250Jun 27, 2018, 05:24 PM
Ruff ShamimSVP, Chief Regulatory AffairsMay 22, 2018 Option Exercise$89.221,305116,43231,936May 24, 2018, 06:06 PM
Mahatme SandeshEVP, CFO & CBOMay 22, 2018 Option Exercise$89.222,024180,58147,286May 24, 2018, 06:05 PM
Howton David TSVP, General CounselMay 22, 2018 Option Exercise$89.221,566139,71934,871May 24, 2018, 06:05 PM
Cumbo AlexanderSVP, Chief Commercial OfficerMay 22, 2018 Option Exercise$89.221,435128,03128,766May 24, 2018, 06:04 PM
Ruff ShamimSVP, Chief Regulatory AffairsMar 15, 2018 Option Exercise$81.2273659,77828,809Mar 16, 2018, 06:13 PM
Ruff ShamimSVP, Chief Regulatory AffairsMar 15, 2018 Option Exercise$23.932,50059,81329,465Mar 16, 2018, 06:13 PM
Howton David TSVP, General CounselMar 15, 2018 Option Exercise$81.2268055,23031,118Mar 16, 2018, 06:12 PM
Howton David TSVP, General CounselMar 15, 2018 Option Exercise$22.152,50055,38231,727Mar 16, 2018, 06:12 PM
Cumbo AlexanderSVP, Chief Commercial OfficerMar 15, 2018 Option Exercise$81.2263351,41225,325Mar 16, 2018, 06:10 PM
Cumbo AlexanderSVP, Chief Commercial OfficerMar 15, 2018 Option Exercise$20.642,50051,60025,767Mar 16, 2018, 06:10 PM
Mahatme SandeshEVP, CFO & CBOMar 15, 2018 Option Exercise$81.2273459,61542,661Mar 16, 2018, 06:08 PM
Mahatme SandeshEVP, CFO & CBOMar 15, 2018 Option Exercise$23.852,50059,62543,395Mar 16, 2018, 06:08 PM
Wigzell Hans Lennart RudolfDirectorNov 30, 2017 Option Exercise$7.386,66749,20213,333Dec 04, 2017, 08:00 PM
Wigzell Hans Lennart RudolfDirectorNov 30, 2017 Sale$55.896,667372,6196,666Dec 04, 2017, 08:00 PM
INGRAM DOUGLAS SPresident & CEONov 08, 2017 Buy$52.4438,1381,999,957420,196Nov 13, 2017, 05:00 PM
Ruff ShamimSVP, Regulatory Affairs & QualNov 06, 2017 Option Exercise$14.7610,000147,60037,045Nov 08, 2017, 08:13 PM
Ruff ShamimSVP, Regulatory Affairs & QualNov 06, 2017 Sale$55.0010,000550,00027,045Nov 08, 2017, 08:13 PM
Ruff ShamimSVP, Regulatory Affairs & QualOct 03, 2017 Option Exercise$14.7611,500169,74038,545Oct 05, 2017, 07:24 PM
Ruff ShamimSVP, Regulatory Affairs & QualOct 03, 2017 Sale$50.0011,500575,00027,045Oct 05, 2017, 07:24 PM
Ruff ShamimSVP, Regulatory Affairs & QualAug 03, 2017 Option Exercise$37.882,882109,17027,045Aug 07, 2017, 04:44 PM
Mahatme SandeshEVP, CFO & CBOAug 03, 2017 Option Exercise$37.886,264237,28040,895Aug 07, 2017, 04:42 PM
Howton David TSVP, General CounselAug 03, 2017 Option Exercise$37.884,642175,83929,298Aug 07, 2017, 04:40 PM
Kaye Edward M. MDDirectorAug 03, 2017 Option Exercise$37.8816,703632,71071,229Aug 07, 2017, 04:39 PM
Cumbo AlexanderSVP, Chief Commercial OfficerAug 03, 2017 Option Exercise$37.883,169120,04223,458Aug 07, 2017, 04:38 PM
INGRAM DOUGLAS SPresident & CEOJul 27, 2017 Buy$42.5047,0581,999,965382,058Jul 28, 2017, 08:51 AM
Mahatme SandeshEVP, CFO & CBOJul 21, 2017 Option Exercise$23.851,50035,77533,861Jul 21, 2017, 09:49 PM
Mahatme SandeshEVP, CFO & CBOJul 20, 2017 Option Exercise$15.3850,000769,10765,359Jul 21, 2017, 09:49 PM
Mahatme SandeshEVP, CFO & CBOJul 20, 2017 Sale$41.0050,0002,050,00032,361Jul 21, 2017, 09:49 PM
Kaye Edward M. MDDirectorJul 20, 2017 Option Exercise$40.934,349178,00562,471Jul 21, 2017, 09:48 PM
Kaye Edward M. MDDirectorJul 20, 2017 Sale$41.0010,000410,00052,471Jul 21, 2017, 09:48 PM
Ruff ShamimSVP, Regulatory Affairs & QualJul 21, 2017 Option Exercise$14.125,88883,13325,450Jul 21, 2017, 09:47 PM
Ruff ShamimSVP, Regulatory Affairs & QualJul 20, 2017 Option Exercise$13.716,25085,68827,312Jul 21, 2017, 09:47 PM
Ruff ShamimSVP, Regulatory Affairs & QualJul 21, 2017 Sale$44.005,888259,07221,062Jul 21, 2017, 09:47 PM
Ruff ShamimSVP, Regulatory Affairs & QualJul 20, 2017 Sale$42.006,250262,50021,062Jul 21, 2017, 09:47 PM
Howton David TSVP, General CounselJul 21, 2017 Option Exercise$20.561,00020,56523,301Jul 21, 2017, 09:46 PM
Howton David TSVP, General CounselJul 20, 2017 Option Exercise$13.7125,000342,75041,357Jul 21, 2017, 09:46 PM
Howton David TSVP, General CounselJul 20, 2017 Sale$41.0025,0001,025,00022,301Jul 21, 2017, 09:46 PM
Cumbo AlexanderSVP, Chief Commercial OfficerJul 20, 2017 Option Exercise$13.712,50034,27522,793Jul 21, 2017, 09:45 PM
Cumbo AlexanderSVP, Chief Commercial OfficerJul 20, 2017 Sale$41.005,918242,63820,293Jul 21, 2017, 09:45 PM
Kaye Edward M. MDPresident & CEOApr 20, 2017 Option Exercise$32.544,349141,51666,820Apr 24, 2017, 05:11 PM
Howton David TSVP, General CounselMar 19, 2017 Option Exercise$30.301524,60622,301Mar 21, 2017, 06:07 PM
Mahatme SandeshEVP, CFO & CBOMar 19, 2017 Option Exercise$30.301715,18132,361Mar 21, 2017, 06:05 PM
Ruff ShamimSVP, Regulatory Affairs & QualMar 19, 2017 Option Exercise$30.301775,36321,062Mar 21, 2017, 06:01 PM
Kaye Edward M. MDPresident, CEO & CMOJan 20, 2017 Option Exercise$32.664,466145,86071,169Jan 24, 2017, 05:52 PM
Howton David TSVP, General CounselNov 09, 2016 Option Exercise$23.851,00023,85022,453Nov 10, 2016, 08:27 AM
Mahatme SandeshSenior Vice President, CFONov 09, 2016 Option Exercise$23.851,00023,85032,532Nov 10, 2016, 08:26 AM
Ruff ShamimSVP, Regulatory Affairs & QualNov 08, 2016 Option Exercise$26.241,00026,24021,239Nov 10, 2016, 08:20 AM
Kaye Edward M. MDPresident, CEO & CMONov 09, 2016 Option Exercise$8.283,00024,84075,635Nov 10, 2016, 08:19 AM
Kaye Edward M. MDPresident, CEO & CMOOct 20, 2016 Option Exercise$49.054,348213,26972,635Oct 24, 2016, 04:33 PM
Mahatme SandeshSenior Vice President, CFOOct 17, 2016 Option Exercise$13.9030,000417,00061,532Oct 19, 2016, 04:22 PM
Mahatme SandeshSenior Vice President, CFOOct 17, 2016 Sale$50.0830,0001,502,50231,532Oct 19, 2016, 04:22 PM
Ruff ShamimSVP, Regulatory Affairs & QualSep 22, 2016 Option Exercise$13.907,311101,62327,550Sep 30, 2016, 09:58 PM
Ruff ShamimSVP, Regulatory Affairs & QualSep 22, 2016 Sale$60.007,311438,66020,239Sep 30, 2016, 09:58 PM
Kaye Edward M. MDPresident, CEO & CMOSep 22, 2016 Option Exercise$8.2840,179332,682117,162Sep 26, 2016, 04:23 PM
Kaye Edward M. MDPresident, CEO & CMOSep 22, 2016 Sale$60.0040,1792,410,74076,983Sep 26, 2016, 04:23 PM
Howton David TSVP, General CounselSep 22, 2016 Option Exercise$13.907,00097,30028,453Sep 26, 2016, 04:19 PM
Howton David TSVP, General CounselSep 22, 2016 Sale$60.007,000420,00021,453Sep 26, 2016, 04:19 PM
Aphale JayantVP, Technical OperationsSep 19, 2016 Option Exercise$4.6235,000161,70036,490Sep 21, 2016, 09:31 PM
Aphale JayantVP, Technical OperationsSep 19, 2016 Sale$50.0035,0001,750,00011,490Sep 21, 2016, 09:31 PM
Kaye Edward M. MDPresident, CEO & CMOSep 19, 2016 Option Exercise$6.9424,352168,94189,983Sep 21, 2016, 09:29 PM
Kaye Edward M. MDPresident, CEO & CMOSep 19, 2016 Sale$50.0024,3521,217,60076,983Sep 21, 2016, 09:29 PM
Howton David TSVP, General CounselSep 19, 2016 Option Exercise$13.908,000111,20011,168Sep 21, 2016, 09:28 PM
Howton David TSVP, General CounselSep 19, 2016 Sale$50.009,304465,20021,453Sep 21, 2016, 09:28 PM
Kaye Edward M. MDSVP Interim CEO & CMOSep 14, 2016 Sale$30.0024,557736,71076,983Sep 16, 2016, 04:04 PM
Kaye Edward M. MDSVP Interim CEO & CMOAug 31, 2016 Option Exercise$26.071,48738,766101,540Sep 02, 2016, 04:43 PM
Mahatme SandeshSenior Vice President, CFOAug 31, 2016 Option Exercise$26.071,01326,4097,102Sep 02, 2016, 04:37 PM
Aphale JayantSVP, Technical OperationsAug 31, 2016 Option Exercise$26.0776519,94411,490Sep 02, 2016, 04:34 PM
Howton David TSVP, General CounselAug 31, 2016 Option Exercise$26.0789823,4113,168Sep 02, 2016, 04:32 PM
Kaye Edward M. MDSVP Interim CEO & CMOJul 20, 2016 Option Exercise$22.463,00167,402103,027Jul 22, 2016, 05:20 PM
Kaye Edward M. MDSVP Interim CEO & CMOApr 20, 2016 Option Exercise$19.713,00159,150106,028Apr 22, 2016, 04:36 PM
BEHRENS M KATHLEENDirectorMar 16, 2016 Buy$14.5410,000145,43321,855Mar 16, 2016, 08:15 PM
BEHRENS M KATHLEENDirectorMar 14, 2016 Buy$16.5465,0001,075,275112,166Mar 16, 2016, 08:15 PM
Barry RichardDirectorMar 14, 2016 Buy$15.6675,0001,174,1853,241,014Mar 16, 2016, 08:09 PM
Price Ben GilDirectorMar 14, 2016 Buy$16.704,50075,14442,830Mar 16, 2016, 08:07 PM
Kaye Edward M. MDSVP Interim CEO & CMOJan 20, 2016 Option Exercise$13.263,36844,660103,525Jan 25, 2016, 01:28 PM
Kaye Edward M. MDSVP Interim CEO & CMOOct 20, 2015 Option Exercise$26.743,00180,247106,893Oct 22, 2015, 06:24 PM
Kaye Edward M. MDSVP Interim CEO & CMOJul 20, 2015 Option Exercise$33.483,000100,440109,094Jul 31, 2015, 04:36 PM
Kaye Edward M. MDSVP & Chief Medical OfficerFeb 27, 2015 Buy$11.818009,4521,311Mar 03, 2015, 06:48 PM
Christopher Nishan GarabedianPresident and CEOFeb 27, 2015 Buy$11.818009,45229,552Mar 03, 2015, 06:47 PM
CHASE ANTHONY RDirectorAug 12, 2014 Option Exercise$10.6823,450250,44666,194Aug 14, 2014, 04:24 PM
Aphale JayantSVP Technical OperationsNov 12, 2013 Sale$12.5615,933200,1348,500Nov 14, 2013, 09:31 PM
CHASE ANTHONY RDirectorNov 14, 2013 Buy$13.9510,000139,48341,744Nov 14, 2013, 09:30 PM
BEHRENS M KATHLEENDirectorSep 16, 2013 Buy$37.046,500240,77844,166Sep 18, 2013, 09:00 AM
HODGMAN JOHNDirectorSep 03, 2013 Option Exercise$17.525,55697,3419,889Sep 05, 2013, 06:26 PM
HODGMAN JOHNDirectorSep 03, 2013 Sale$34.975,556194,3164,333Sep 05, 2013, 06:26 PM
CHASE ANTHONY RDirectorAug 22, 2013 Buy$32.683,500114,37331,744Aug 23, 2013, 09:01 AM
Price Ben GilDirectorAug 19, 2013 Buy$31.1750015,58735,330Aug 20, 2013, 04:08 PM
Mahatme SandeshSenior Vice President, CFOAug 20, 2013 Buy$31.105,000155,5005,000Aug 20, 2013, 01:42 PM
CHASE ANTHONY RDirectorJun 14, 2013 Buy$38.5010,000385,04328,244Jun 18, 2013, 04:51 PM
CHASE ANTHONY RDirectorNov 28, 2012 Sale$29.528,900262,68924,544Nov 29, 2012, 01:46 PM
CHASE ANTHONY RDirectorNov 27, 2012 Sale$29.041,10031,94026,144Nov 29, 2012, 01:46 PM
CHASE ANTHONY RDirectorNov 14, 2012 Sale$25.7010,000257,00228,044Nov 15, 2012, 07:12 PM
CHASE ANTHONY RDirectorSep 07, 2012 Sale$14.4533,000476,95956,944Sep 11, 2012, 05:40 PM
BEHRENS M KATHLEENDirectorSep 07, 2012 Buy$14.7317,500257,72436,666Sep 11, 2012, 05:40 PM
Price Ben GilDirectorMar 14, 2012 Buy$1.2930,00038,850197,982Mar 15, 2012, 01:37 PM
Christopher Nishan GarabedianPresident and CEODec 15, 2011 Buy$0.58300,000173,640430,000Dec 16, 2011, 11:48 AM
CHASE ANTHONY RDirectorSep 13, 2011 Buy$1.2020,00024,000416,467Sep 14, 2011, 05:45 PM
Price Ben GilDirectorApr 06, 2011 Buy$1.5020,00030,000162,982Apr 06, 2011, 05:38 PM
Christopher Nishan GarabedianPresident and CEOApr 06, 2011 Buy$1.50130,000195,000130,000Apr 06, 2011, 05:37 PM
BEHRENS M KATHLEENDirectorApr 06, 2011 Buy$1.50100,000150,000105,000Apr 06, 2011, 05:36 PM
BOYLE J DAVID IICEOAug 27, 2010 Buy$2.135,00010,64570,282Aug 27, 2010, 06:02 PM
Price Ben GilDirectorAug 13, 2010 Buy$1.934,0007,720102,982Aug 16, 2010, 03:17 PM
Hudson LeslieFormer CEOJul 30, 2010 Option Exercise$1.09183,486200,000568,045Aug 02, 2010, 07:28 PM
Hudson LeslieFormer CEOJul 30, 2010 Sale$1.93183,486354,113518,045Aug 02, 2010, 07:28 PM
Hudson LeslieFormer CEOJul 28, 2010 Option Exercise$1.09183,486200,000568,045Jul 29, 2010, 08:00 PM
Hudson LeslieFormer CEOJul 28, 2010 Sale$1.82183,486334,373498,045Jul 29, 2010, 08:00 PM
Hudson LeslieFormer CEOJul 26, 2010 Option Exercise$1.45129,083187,170513,642Jul 28, 2010, 12:48 PM
Hudson LeslieFormer CEOJul 26, 2010 Sale$1.90129,083245,897509,559Jul 28, 2010, 12:48 PM
Hudson LeslieFormer CEOJul 23, 2010 Option Exercise$1.45205,400297,830589,959Jul 26, 2010, 05:37 PM
Hudson LeslieFormer CEOJul 23, 2010 Sale$1.80205,400369,720384,559Jul 26, 2010, 05:37 PM
Hudson LeslieFormer CEOJul 22, 2010 Option Exercise$1.45265,517385,000650,076Jul 23, 2010, 05:06 PM
Hudson LeslieFormer CEOJul 22, 2010 Sale$1.80265,517477,513596,280Jul 23, 2010, 05:06 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Murray DallanChief Customer Officer05/02/2024508,900
Wigzell Hans Lennart RudolfDirector03/08/2024208,500
Wigzell Hans Lennart RudolfDirector03/08/20241,848,795
Arif BilalChief Tech Ops Officer03/08/202458,122
Arif BilalChief Tech Ops Officer03/07/202460,968
Rodino-Klapac LouiseHead of R&D, CSO03/07/202461,691
Rodino-Klapac LouiseHead of R&D, CSO03/08/2024111,934
Boor Kathryn JeanDirector03/11/202493,550
Brown Ryan EdwardEVP, General Counsel03/08/2024110,703
Brown Ryan EdwardEVP, General Counsel03/07/202460,968
Estepan Ian MichaelChief Financial Officer03/08/2024127,450
Estepan Ian MichaelChief Financial Officer03/07/202463,378
Estepan Ian MichaelChief Financial Officer03/04/2024174,069
Mayo StephenDirector03/05/2024385,480
Brown Ryan EdwardEVP, General Counsel03/04/2024217,305
Arif BilalChief Tech Ops Officer03/04/202465,417
Rodino-Klapac LouiseHead of R&D, CSO03/04/2024216,553
Arif BilalChief Tech Ops Officer03/01/202446,059
Arif BilalChief Tech Ops Officer03/01/2024257,676
Estepan Ian MichaelChief Financial Officer03/01/202446,059
Estepan Ian MichaelChief Financial Officer03/01/2024153,960
Brown Ryan EdwardEVP, General Counsel03/01/202433,945
Brown Ryan EdwardEVP, General Counsel03/01/2024250,680
Rodino-Klapac LouiseHead of R&D, CSO03/01/202498,176
Arif BilalChief Tech Ops Officer12/01/2023295,812
Rodino-Klapac LouiseHead of R&D, CSO11/17/2023374,074
Barry RichardDirector11/03/2023788,100
Barry RichardDirector11/03/20233,152,400
INGRAM DOUGLAS SPresident & CEO11/03/20232,001,800
BEHRENS M KATHLEENDirector11/03/2023435,450
Chambers Michael AndrewDirector08/14/20231,092,429
Chambers Michael AndrewDirector08/11/20232,559,272
Chambers Michael AndrewDirector08/10/20233,701,067
Wigzell Hans Lennart RudolfDirector08/04/2023435,450
Wigzell Hans Lennart RudolfDirector08/04/20231,600,800
Brown Ryan EdwardEVP, General Counsel06/01/202311,000
Arif BilalChief Tech Ops Officer03/30/202341,955
Rodino-Klapac LouiseHead of R&D, CSO03/08/2023139,709
Estepan Ian MichaelChief Financial Officer03/08/2023113,973
Brown Ryan EdwardSVP, General Counsel03/08/202397,276
Arif BilalChief Tech Ops Officer03/08/202348,102
Arif BilalChief Tech Ops Officer03/06/202353,451
Estepan Ian MichaelChief Financial Officer03/06/2023215,378
Rodino-Klapac LouiseHead of R&D, CSO03/06/2023178,276
Brown Ryan EdwardSVP, General Counsel03/06/2023208,303
Arif BilalChief Tech Ops Officer03/01/202337,188
Brown Ryan EdwardSVP, General Counsel03/01/202328,924
Estepan Ian MichaelChief Financial Officer03/01/202355,781
Rodino-Klapac LouiseHead of R&D, CSO03/01/202377,032
BEHRENS M KATHLEENDirector12/19/2022698,400
Rodino-Klapac LouiseHead of R&D, CSO11/17/2022456,978
Mayo StephenDirector11/17/202294,311
Chambers Michael AndrewDirector09/14/20225,963,124
Chambers Michael AndrewDirector08/19/20224,999,230
Brown Ryan EdwardSVP, General Counsel06/01/20223,924
Estepan Ian MichaelChief Financial Officer03/07/202231,585
Estepan Ian MichaelChief Financial Officer03/04/2022103,594
Brown Ryan EdwardSVP, General Counsel03/07/202212,142
Brown Ryan EdwardSVP, General Counsel03/04/202289,971
Ciambrone WilliamEVP03/04/202291,872
Rodino-Klapac LouiseHead of R&D, CSO03/04/202296,307
Rodino-Klapac LouiseHead of R&D, CSO03/01/202242,929
Estepan Ian MichaelChief Financial Officer03/01/202228,219
Brown Ryan EdwardSVP, General Counsel03/01/202213,809
BEHRENS M KATHLEENDirector12/15/202150,400
Rodino-Klapac LouiseHead of R&D, CSO11/24/2021299,867
INGRAM DOUGLAS SPresident & CEO11/17/20212,000,579
Estepan Ian MichaelChief Financial Officer09/08/2021127,065
INGRAM DOUGLAS SPresident & CEO06/26/20211,432,085
BEHRENS M KATHLEENDirector03/10/2021211,500
BEHRENS M KATHLEENDirector03/10/2021428,800
Wigzell Hans Lennart RudolfDirector03/08/2021349,200
Wigzell Hans Lennart RudolfDirector03/08/2021835,100
O'Neill Gilmore NeilEVP, R&D & CMO02/28/202145,572
Brown Ryan EdwardSVP, General Counsel03/04/202115,344
Brown Ryan EdwardSVP, General Counsel02/28/202118,786
Rodino-Klapac LouiseChief Scientific Officer02/28/202149,138
Estepan Ian MichaelChief Financial Officer02/28/202127,743
Estepan Ian MichaelChief Financial Officer03/05/202129,374
INGRAM DOUGLAS SPresident & CEO12/31/20206,332,681
Bratica JosephPrincipal Financial Officer12/11/202079,667
Bratica JosephPrincipal Financial Officer12/11/2020183,975
Bratica JosephPrincipal Financial Officer12/08/202033,300
Bratica JosephPrincipal Financial Officer12/08/2020180,000
Wigzell Hans Lennart RudolfDirector08/10/2020349,200
Wigzell Hans Lennart RudolfDirector08/10/20201,590,044
Barry RichardDirector08/07/20204,754,972
Bratica JosephPrincipal Financial Officer08/03/202033,300
Bratica JosephPrincipal Financial Officer08/03/2020174,375
Mahatme SandeshEVP, CFO & CBO07/08/202074,941
Howton David TEVP, General Counsel06/22/20202,708,440
Howton David TEVP, General Counsel06/22/202017,962,831
Wigzell Hans Lennart RudolfDirector05/20/202050,400
Wigzell Hans Lennart RudolfDirector05/20/2020753,210
Barry RichardDirector05/15/20204,237,946
Wigzell Hans Lennart RudolfDirector03/04/202042,300
Wigzell Hans Lennart RudolfDirector03/04/2020584,450
INGRAM DOUGLAS SPresident & CEO12/31/20194,798,352
Cumbo AlexanderEVP, Chief Commercial Officer12/13/2019775,232
Cumbo AlexanderEVP, Chief Commercial Officer12/13/20195,271,000
Howton David TEVP, General Counsel12/13/20191,675,439
Howton David TEVP, General Counsel12/13/20199,789,000
Mahatme SandeshEVP, CFO & CBO12/13/20193,610,443
Mahatme SandeshEVP, CFO & CBO12/13/201915,687,500
Howton David TEVP, General Counsel11/22/2019300,084
Howton David TEVP, General Counsel11/22/2019552,667
Howton David TEVP, General Counsel11/22/20192,625,000
Barry RichardDirector09/13/2019289,504
Barry RichardDirector09/12/2019147,950
BONNEY MICHAEL WDirector09/09/2019173,480
BEHRENS M KATHLEENDirector09/05/201939,000
BEHRENS M KATHLEENDirector09/06/2019219,950
Mahatme SandeshEVP, CFO & CBO08/21/20195,832,698
Mahatme SandeshEVP, CFO & CBO08/21/20192,385,000
Barry RichardDirector08/20/2019496,592
Mahatme SandeshEVP, CFO & CBO08/15/2019241,232
Barry RichardDirector08/14/2019453,250
Barry RichardDirector08/12/2019159,250
INGRAM DOUGLAS SPresident & CEO08/12/20192,000,160
O'Neill Gilmore NeilEVP, R&D & CMO05/24/2019552,405
Wigzell Hans Lennart RudolfDirector05/23/201978,000
Wigzell Hans Lennart RudolfDirector05/23/20191,200,000
Mahatme SandeshEVP, CFO & CBO03/28/2019350,462
Howton David TEVP, General Counsel03/28/2019280,322
Cumbo AlexanderEVP, Chief Commercial Officer03/28/2019256,942
Mahatme SandeshEVP, CFO & CBO03/19/2019331,984
Mahatme SandeshEVP, CFO & CBO03/19/2019332,308
Mahatme SandeshEVP, CFO & CBO02/07/20191,550,250
Mahatme SandeshEVP, CFO & CBO02/07/20199,425,000
Cumbo AlexanderSVP, Chief Commercial Officer02/01/2019169,035
Cumbo AlexanderSVP, Chief Commercial Officer02/01/20192,100,000
Howton David TSVP, General Counsel02/01/2019465,391
Howton David TSVP, General Counsel02/01/20194,200,000
Mahatme SandeshEVP, CFO & CBO01/31/2019505,572
Mahatme SandeshEVP, CFO & CBO01/30/2019800,077
Mahatme SandeshEVP, CFO & CBO01/31/20192,771,003
Mahatme SandeshEVP, CFO & CBO01/30/20195,694,260
Wigzell Hans Lennart RudolfDirector11/01/201859,603
Wigzell Hans Lennart RudolfDirector11/01/2018936,714
BEHRENS M KATHLEENDirector10/31/201839,600
BEHRENS M KATHLEENDirector10/31/20181,317,100
INGRAM DOUGLAS SPresident & CEO10/30/20182,009,872
Mahatme SandeshEVP, CFO & CBO10/24/20181,330,389
Mahatme SandeshEVP, CFO & CBO10/24/201813,735,116
INGRAM DOUGLAS SPresident & CEO08/15/20182,004,208
Cumbo AlexanderSVP, Chief Commercial Officer08/08/2018726,120
Howton David TSVP, General Counsel08/08/2018822,936
Mahatme SandeshEVP, CFO & CBO08/08/20181,028,791
Howton David TSVP, General Counsel07/16/2018692,691
Howton David TSVP, General Counsel07/16/20186,823,000
Cumbo AlexanderSVP, Chief Commercial Officer07/09/2018465,415
Cumbo AlexanderSVP, Chief Commercial Officer07/09/20184,638,944
Barry RichardDirector06/27/20189,775,500
INGRAM DOUGLAS SPresident & CEO06/26/20185,007,291
Ruff ShamimSVP, Chief Regulatory Affairs05/22/2018116,432
Mahatme SandeshEVP, CFO & CBO05/22/2018180,581
Howton David TSVP, General Counsel05/22/2018139,719
Cumbo AlexanderSVP, Chief Commercial Officer05/22/2018128,031
Ruff ShamimSVP, Chief Regulatory Affairs03/15/201859,778
Ruff ShamimSVP, Chief Regulatory Affairs03/15/201859,813
Howton David TSVP, General Counsel03/15/201855,230
Howton David TSVP, General Counsel03/15/201855,382
Cumbo AlexanderSVP, Chief Commercial Officer03/15/201851,412
Cumbo AlexanderSVP, Chief Commercial Officer03/15/201851,600
Mahatme SandeshEVP, CFO & CBO03/15/201859,615
Mahatme SandeshEVP, CFO & CBO03/15/201859,625
Wigzell Hans Lennart RudolfDirector11/30/201749,202
Wigzell Hans Lennart RudolfDirector11/30/2017372,619
INGRAM DOUGLAS SPresident & CEO11/08/20171,999,957
Ruff ShamimSVP, Regulatory Affairs & Qual11/06/2017147,600
Ruff ShamimSVP, Regulatory Affairs & Qual11/06/2017550,000
Ruff ShamimSVP, Regulatory Affairs & Qual10/03/2017169,740
Ruff ShamimSVP, Regulatory Affairs & Qual10/03/2017575,000
Ruff ShamimSVP, Regulatory Affairs & Qual08/03/2017109,170
Mahatme SandeshEVP, CFO & CBO08/03/2017237,280
Howton David TSVP, General Counsel08/03/2017175,839
Kaye Edward M. MDDirector08/03/2017632,710
Cumbo AlexanderSVP, Chief Commercial Officer08/03/2017120,042
INGRAM DOUGLAS SPresident & CEO07/27/20171,999,965
Mahatme SandeshEVP, CFO & CBO07/21/201735,775
Mahatme SandeshEVP, CFO & CBO07/20/2017769,107
Mahatme SandeshEVP, CFO & CBO07/20/20172,050,000
Kaye Edward M. MDDirector07/20/2017178,005
Kaye Edward M. MDDirector07/20/2017410,000
Ruff ShamimSVP, Regulatory Affairs & Qual07/21/201783,133
Ruff ShamimSVP, Regulatory Affairs & Qual07/20/201785,688
Ruff ShamimSVP, Regulatory Affairs & Qual07/21/2017259,072
Ruff ShamimSVP, Regulatory Affairs & Qual07/20/2017262,500
Howton David TSVP, General Counsel07/21/201720,565
Howton David TSVP, General Counsel07/20/2017342,750
Howton David TSVP, General Counsel07/20/20171,025,000
Cumbo AlexanderSVP, Chief Commercial Officer07/20/201734,275
Cumbo AlexanderSVP, Chief Commercial Officer07/20/2017242,638
Kaye Edward M. MDPresident & CEO04/20/2017141,516
Howton David TSVP, General Counsel03/19/20174,606
Mahatme SandeshEVP, CFO & CBO03/19/20175,181
Ruff ShamimSVP, Regulatory Affairs & Qual03/19/20175,363
Kaye Edward M. MDPresident, CEO & CMO01/20/2017145,860
Howton David TSVP, General Counsel11/09/201623,850
Mahatme SandeshSenior Vice President, CFO11/09/201623,850
Ruff ShamimSVP, Regulatory Affairs & Qual11/08/201626,240
Kaye Edward M. MDPresident, CEO & CMO11/09/201624,840
Kaye Edward M. MDPresident, CEO & CMO10/20/2016213,269
Mahatme SandeshSenior Vice President, CFO10/17/2016417,000
Mahatme SandeshSenior Vice President, CFO10/17/20161,502,502
Ruff ShamimSVP, Regulatory Affairs & Qual09/22/2016101,623
Ruff ShamimSVP, Regulatory Affairs & Qual09/22/2016438,660
Kaye Edward M. MDPresident, CEO & CMO09/22/2016332,682
Kaye Edward M. MDPresident, CEO & CMO09/22/20162,410,740
Howton David TSVP, General Counsel09/22/201697,300
Howton David TSVP, General Counsel09/22/2016420,000
Aphale JayantVP, Technical Operations09/19/2016161,700
Aphale JayantVP, Technical Operations09/19/20161,750,000
Kaye Edward M. MDPresident, CEO & CMO09/19/2016168,941
Kaye Edward M. MDPresident, CEO & CMO09/19/20161,217,600
Howton David TSVP, General Counsel09/19/2016111,200
Howton David TSVP, General Counsel09/19/2016465,200
Kaye Edward M. MDSVP Interim CEO & CMO09/14/2016736,710
Kaye Edward M. MDSVP Interim CEO & CMO08/31/201638,766
Mahatme SandeshSenior Vice President, CFO08/31/201626,409
Aphale JayantSVP, Technical Operations08/31/201619,944
Howton David TSVP, General Counsel08/31/201623,411
Kaye Edward M. MDSVP Interim CEO & CMO07/20/201667,402
Kaye Edward M. MDSVP Interim CEO & CMO04/20/201659,150
BEHRENS M KATHLEENDirector03/16/2016145,433
BEHRENS M KATHLEENDirector03/14/20161,075,275
Barry RichardDirector03/14/20161,174,185
Price Ben GilDirector03/14/201675,144
Kaye Edward M. MDSVP Interim CEO & CMO01/20/201644,660
Kaye Edward M. MDSVP Interim CEO & CMO10/20/201580,247
Kaye Edward M. MDSVP Interim CEO & CMO07/20/2015100,440
Kaye Edward M. MDSVP & Chief Medical Officer02/27/20159,452
Christopher Nishan GarabedianPresident and CEO02/27/20159,452
CHASE ANTHONY RDirector08/12/2014250,446
Aphale JayantSVP Technical Operations11/12/2013200,134
CHASE ANTHONY RDirector11/14/2013139,483
BEHRENS M KATHLEENDirector09/16/2013240,778
HODGMAN JOHNDirector09/03/201397,341
HODGMAN JOHNDirector09/03/2013194,316
CHASE ANTHONY RDirector08/22/2013114,373
Price Ben GilDirector08/19/201315,587
Mahatme SandeshSenior Vice President, CFO08/20/2013155,500
CHASE ANTHONY RDirector06/14/2013385,043
CHASE ANTHONY RDirector11/28/2012262,689
CHASE ANTHONY RDirector11/27/201231,940
CHASE ANTHONY RDirector11/14/2012257,002
CHASE ANTHONY RDirector09/07/2012476,959
BEHRENS M KATHLEENDirector09/07/2012257,724
Price Ben GilDirector03/14/201238,850
Christopher Nishan GarabedianPresident and CEO12/15/2011173,640
CHASE ANTHONY RDirector09/13/201124,000
Price Ben GilDirector04/06/201130,000
Christopher Nishan GarabedianPresident and CEO04/06/2011195,000
BEHRENS M KATHLEENDirector04/06/2011150,000
BOYLE J DAVID IICEO08/27/201010,645
Price Ben GilDirector08/13/20107,720
Hudson LeslieFormer CEO07/30/2010200,000
Hudson LeslieFormer CEO07/30/2010354,113
Hudson LeslieFormer CEO07/28/2010200,000
Hudson LeslieFormer CEO07/28/2010334,373
Hudson LeslieFormer CEO07/26/2010187,170
Hudson LeslieFormer CEO07/26/2010245,897
Hudson LeslieFormer CEO07/23/2010297,830
Hudson LeslieFormer CEO07/23/2010369,720
Hudson LeslieFormer CEO07/22/2010385,000
Hudson LeslieFormer CEO07/22/2010477,513
Load More Insider Transactions
FUNDS WITH A POSITION IN SAREPTA THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BlackRock Inc.10,124,4310.03%69.86%Other
FARALLON CAPITAL MANAGEMENT LLC2,453,5001.44%102.76%Event Driven, Value
GEODE CAPITAL MANAGEMENT, LLC1,520,3700.02%3.46%Other
ORBIMED ADVISORS LLC697,5001.65%No changeOther
RENAISSANCE TECHNOLOGIES LLC390,2780.08%-30.68%Other
BALYASNY ASSET MANAGEMENT L.P.509,2050.12%2.08%Event Driven
ADAGE CAPITAL PARTNERS GP, L.L.C.470,0000.11%NewOther
D. E. SHAW & CO., INC.86,8660.00962%-75.57%Other
PALO ALTO INVESTORS LP201,2652.94%0.18%Other
CANDRIAM S.C.A.151,0000.13%-17.24%Other
TUDOR INVESTMENT CORP ET AL62,8000.05%ExitedEvent Driven, Other
BALYASNY ASSET MANAGEMENT L.P.43,800 (Put)0.00793%ExitedEvent Driven
OCONNOR, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS (LLC)35,000 (Call)0.02%NewValue
BRIDGEWATER ASSOCIATES, LP23,2220.02%-12%Other
OCONNOR, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS (LLC)6,8130.06%-70.52%Value
FISHER ASSET MANAGEMENT, LLC18,0210.00109%32.34%Other
PLATINUM INVESTMENT MANAGEMENT LTD10,2750.05%No changeGrowth At A Reasonable Price, Value
WCM INVESTMENT MANAGEMENT, LLC6,2790.00193%2.31%Growth At A Reasonable Price
SOROS FUND MANAGEMENT LLC3,9560.00851%NewOther
CHANGE IN SHARES OUTSTANDING FOR SAREPTA THERAPEUTICS INC
STOCK BUYBACKS FOR SAREPTA THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
16.74%
1Q
12/31/2023
06/30/2023
16.93%
2Q
12/31/2023
03/31/2023
17.67%
3Q
12/31/2023
12/31/2022
18.13%
4Q
12/31/2023
09/30/2022
18.42%
5Q
12/31/2023
06/30/2022
18.57%
6Q
12/31/2023
03/31/2022
18.92%
7Q
12/31/2023
12/31/2021
20.71%
8Q
12/31/2023
09/30/2021
29.90%
9Q
12/31/2023
06/30/2021
30.12%
10Q
12/31/2023
03/31/2021
30.60%
11Q
12/31/2023
12/31/2020
31.49%
12Q
12/31/2023
09/30/2020
32.18%
13Q
12/31/2023
06/30/2020
33.09%
14Q
12/31/2023
03/31/2020
35.76%
15Q
12/31/2023
12/31/2019
39.16%
16Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
16.74%
1Q
06/30/2023
16.93%
2Q
03/31/2023
17.67%
3Q
12/31/2022
18.13%
4Q
09/30/2022
18.42%
5Q
06/30/2022
18.57%
6Q
03/31/2022
18.92%
7Q
12/31/2021
20.71%
8Q
09/30/2021
29.90%
9Q
06/30/2021
30.12%
10Q
03/31/2021
30.60%
11Q
12/31/2020
31.49%
12Q
09/30/2020
32.18%
13Q
06/30/2020
33.09%
14Q
03/31/2020
35.76%
15Q
12/31/2019
39.16%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR SAREPTA THERAPEUTICS INC
LOADING...